The Food and Drug Administration is once again the target of public ire over its seemingly glacial response to a U.S. consumer crisis. A recent story posted to Politico indicates that parents and their congressional representatives have begun raising serious questions about the amount of time that elapsed between the discovery of the first illness allegedly associated with infant formula contamination and the government’s response ...
FDA Under Fire Over Failure to React to Baby Formula Crisis
Posted March 22, 2022 in Product News and Recalls | Recall
Parents on Edge as Baby Formula Illnesses Continue
Posted March 16, 2022 in Product News and Recalls | Recall
The number of infants killed by the contamination of a variety of batches of baby formula at a Sturgis, Michigan Abbott Laboratories facility may have risen as another death has recently been reported and regulators question how many illnesses have gone unreported.
Information has also been made public that shows that reports of infant illnesses and their potential ties to the Sturgis facility continue reading...
Spotlight Back on Abbott After Study Reveals Problems with Dissolving Stent
Posted April 28, 2017 in Drug and Medical Device Lawsuits | Product News and Recalls
Dissolving medical products like stents and sutures are, in theory, a great idea. After all, if a patient can avoid the discomfort and risks that come with additional medical procedures or monitoring, then the benefits seem pretty clear.
The concept behind dissolving medical products is a simple one. After the devices have served their purpose, they simply dissolve over time and are absorbed by the body. If you’ve ever had ...
continue reading...Epilepsy Drug Lawsuit Results in $15 Million Verdict
Posted June 9, 2015 in Drug and Medical Device Lawsuits | Product News and Recalls
We recently posted an update detailing the 4.3% rise in AbbVie’s first-quarter profits. One year ago, the pharmaceutical giant posted profits of $980 million for the first three months of 2014. That, apparently, wasn’t enough. The first three months of 2015 saw profits of $1.02 billion for the Androgel manufacturer.
Profit is not a bad thing. Profit is how bills are paid, families are fed, and companies are ...
continue reading...
